Buspirone does not cause dementia. There is no clinical evidence linking buspirone to cognitive decline, neurodegeneration, or increased dementia risk. In fact, early research suggests the drug may have neuroprotective properties, and it is considered one of the safer anxiety medications for older adults precisely because it avoids the brain pathways most associated with cognitive harm.
Why Buspirone Works Differently Than Other Anxiety Drugs
Much of the concern about anxiety medications and dementia comes from research on benzodiazepines, a different class of drugs that includes diazepam, lorazepam, and alprazolam. Benzodiazepines work by enhancing GABA activity in the brain, which produces sedation and can impair memory formation, especially with long-term use in older adults. Several large studies have linked prolonged benzodiazepine use to elevated dementia risk.
Buspirone has no effect on GABA receptors at all. It works primarily as a partial activator of serotonin 5-HT1A receptors, with weak activity at certain dopamine receptors. This completely different mechanism is why buspirone doesn’t cause sedation, physical dependence, or withdrawal, and why it lacks the cognitive concerns tied to benzodiazepines. If you’ve seen warnings about anxiety medications and dementia, those warnings almost certainly apply to benzodiazepines, not buspirone.
What the FDA Label Actually Says
The FDA-approved prescribing information for buspirone contains no warnings about dementia or long-term cognitive decline. It does note that the drug’s effectiveness beyond three to four weeks hasn’t been established in controlled trials, but a separate study followed 264 patients taking buspirone for a full year “without ill effect.” The label also states that buspirone is less sedating than other anxiety medications and does not produce significant functional impairment.
In post-marketing surveillance (voluntary reports collected after a drug reaches the market), there have been rare mentions of “transient difficulty with recall.” The FDA notes that because these reports are uncontrolled, a causal relationship to buspirone has not been established. Transient memory difficulty is a far cry from dementia, and it’s worth noting that anxiety itself commonly causes concentration problems and forgetfulness that can feel alarming.
Side Effects That Can Mimic Cognitive Problems
Some people taking buspirone experience dizziness, drowsiness, or decreased concentration. These are recognized side effects that typically emerge early in treatment and often improve as your body adjusts to the medication. They can feel unsettling, especially if you’re already worried about your memory, but they reflect temporary changes in alertness rather than any structural brain damage or neurodegeneration.
Less common side effects include blurred vision, trouble sleeping, and unusual tiredness. All of these can contribute to a foggy, distracted feeling that some people describe as “brain fog.” If these symptoms persist or bother you, they’re worth discussing with your prescriber, but they don’t indicate dementia or permanent cognitive harm.
Early Evidence of Neuroprotective Effects
Some of the most interesting research on buspirone actually points in the opposite direction of cognitive harm. A 2022 study published in PMC examined buspirone’s effects in a mouse model of Parkinson’s disease. At higher doses, buspirone prevented the degeneration of dopamine-producing neurons, reduced brain inflammation by lowering levels of inflammatory molecules (interleukin-1β and interleukin-6), and boosted production of brain-derived neurotrophic factor (BDNF), a protein critical for maintaining healthy neurons and forming new connections.
These protective effects were observed across multiple brain regions, including the hippocampus, which is the area most vulnerable to Alzheimer’s-related damage. Buspirone also improved mitochondrial function (the energy-producing machinery inside cells) and enhanced antioxidant activity. The researchers concluded that buspirone showed “neuroprotective efficacy” and suggested it could have potential as a therapeutic agent in neurodegenerative diseases. This is animal research and hasn’t been confirmed in human dementia trials, but it further undermines the idea that buspirone harms the brain.
Untreated Anxiety Is the Bigger Cognitive Risk
If you’re considering stopping buspirone out of fear it might cause dementia, it’s worth understanding what untreated anxiety does to the brain over time. A meta-analysis of nine prospective studies covering nearly 30,000 participants found that people with anxiety had a 24% higher risk of developing dementia compared to those without anxiety. That effect size is comparable to low education, which is an established dementia risk factor. The researchers estimated that roughly 4% of dementia cases could potentially be avoided if anxiety were effectively prevented or treated.
An earlier meta-analysis found an even steeper association: older adults with anxiety had a 57% higher risk of developing dementia. Chronic anxiety floods the brain with stress hormones, disrupts sleep, and promotes inflammation, all of which are known contributors to cognitive decline over time. Effectively managing anxiety with a safe medication like buspirone may actually be protective for long-term brain health, though this hasn’t been directly tested in a clinical trial.
Buspirone and the Beers Criteria for Older Adults
The American Geriatrics Society maintains the Beers Criteria, a widely used list of medications considered potentially inappropriate for older adults due to safety concerns. Benzodiazepines are prominently featured on this list because of their association with falls, confusion, and cognitive impairment in seniors. Buspirone is not flagged on the Beers Criteria as a potentially inappropriate medication. In geriatric medicine, it is often recommended as a preferred alternative to benzodiazepines specifically because of its cleaner safety profile in older adults.
This distinction matters. When clinicians are concerned about cognitive safety in an elderly patient with anxiety, buspirone is frequently the medication they turn to, not away from. Its lack of sedation, absence of dependence risk, and clean cognitive profile make it one of the most cautious choices available for treating anxiety in people who are already at elevated risk for dementia due to age.